S9, a novel anticancer agent, exerts its anti -proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton

	S9, a novel anticancer agent, exerts its anti -proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton
	Zhang, Chao; Yang, Na; Yang, Chun-Hao; Ding, Hua-Sheng; Luo, Cheng; Zhang, Yu; Wu, Mao-Jiang; Zhang, Xiong-Wen; Shen, Xu; Jiang, Hua-Liang
	2009-05-01
卷号	69
会议录	CANCER RESEARCH
会议录出版者	AMER ASSOC CANCER RESEARCH
文献子类	Meeting Abstract
语种	英语
WOS研究方向	Oncology
WOS记录号	WOS:000209701802463
内容类型	会议论文
源URL	[http://119.78.100.183/handle/2S10ELR8/266233]
专题	药物化学研究室药物发现与设计中心药理学第一研究室
作者单位	Shanghai Inst Mat Med, Shanghai, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Chao,Yang, Na,Yang, Chun-Hao,et al. S9, a novel anticancer agent, exerts its anti -proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton[C]. 见:.